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AbsTrACT
The Rapid Assessment of Avoidable Blindness, or RAAB, 
is a relatively simple and low-cost survey methodology to 
provide data on the prevalence and causes of visual loss. 
The aim of this article is to reflect on the achievements 
and challenges of RAAB, and to describe the future 
developments that are needed to ensure that it remains 
a relevant and widely used tool. To date, at least 331 
RAABs have been undertaken in 79 countries, and these 
surveys provide an important source of information on 
visual loss at both the local and global level. A RAAB 
repository has been developed which includes the site 
and date of RAABs undertaken, and, where authors have 
agreed, the core indicators, reports or even raw data 
from the survey. This dataset has already been used for 
meta-analyses, and there are further opportunities for its 
use. Despite these achievements, there are core areas in 
which RAAB needs to be strengthened so that the full 
benefits of undertaking the survey can be reaped. Key 
developments of RAAB are underway, and will include 
greater use of mobile technologies using a cloud-based 
platform to enable both digital data collection, real-time 
survey reviews, reporting and analysis, and a greater 
emphasis on using the data for planning.
InTroduCTIon
The Rapid Assessment of Avoidable Blindness 
(RAAB) is a survey methodology that aims to provide 
data on the prevalence and causes of visual loss 
(box 1).1 The RAAB approach is relatively simple 
and low-cost as it focuses mainly on assessing avoid-
able causes of visual loss, such as cataract, refrac-
tive error and corneal scarring. This approach is in 
keeping with the aim of the International Agency 
for Prevention of Blindness (IAPB) VISION 2020: 
The Right to Sight programme to eliminate 80% of 
avoidable blindness by 2020. The intention is that 
the RAAB data are used to plan eye care services, 
so that they can target the most important local 
priorities, such as increasing the number of cataract 
surgeries, improving surgical quality or providing 
more spectacles. RAAB can also be used to monitor 
whether there have been changes in the prevalence 
and causes of eye conditions, when repeated RAABs 
are conducted in the same area. RAAB was devel-
oped by Hans Limburg working with the Inter-
national Centre for Eye Health, first as the Rapid 
Assessment of Cataract Surgical Services in 1997, 
and then updated and modified to create RAAB in 
2004.1–4
Recently, RAAB has been updated as it moved 
to a mobile data collection form, through the 
development of ‘mobile RAAB’ (mRAAB). 
Currently, a new version of RAAB is under develop-
ment, described in detail below, which will facilitate 
greater use of mobile technologies and a greater 
emphasis on using the data for planning. At the 
same time, a new strategic focus on universal eye 
health coverage through health system strength-
ening will require key indicators to be collected 
on coverage, and an increasing focus of posterior 
segment disorders is needed as these conditions are 
gaining importance. We are, therefore, at a critical 
juncture with RAAB. The aim of this article is to 
reflect on the achievements and challenges of RAAB 
to date, and to describe the future developments 
that are needed to ensure that it remains a relevant 
and widely used tool.
WhAT Is rAAb?
More detail on the exact methodology of RAAB 
is available from other sources.1 5 In brief, within 
any survey, including RAAB, there are two critical 
stages. The first is the selection of the sample of 
the population. The second is the examination of 
selected participants to assess whether or not the 
participant screened has the condition of interest. 
For RAAB, these procedures are undertaken as 
follows:
 ► Sampling: A district, province or country for the 
RAAB survey is identified by key stakeholders. 
Within this particular area, a population-based 
sample of around 2500–5000 residents aged 50 
years and above is selected, through sampling 
50–100 clusters of 50 people. The clusters are 
systematically sampled using probably propor-
tional to size from a sampling frame consisting 
of all census enumeration areas in the survey. 
Within a cluster, the 50 participants are 
selected through a procedure called compact 
segment sampling. Typically, 3–5 survey teams 
conduct the fieldwork, each consisting of one 
ophthalmic clinician (eg, an ophthalmologist), 
one person capable of undertaking visual acuity 
assessment (eg, optometrist or ophthalmic assis-
tant and refractionist) and a village guide. The 
participants are examined in their household, 
and the teams move door-to-door, to maximise 
response rate. One cluster of 50 residents aged 
50 years or older is completed per team per day.
 ► Examination: The key measure of interest in 
the RAAB is visual impairment. Each eligible 
person selected for the RAAB is invited to 
undergo visual acuity screening, using a 
tumbling E chart. He/she is also assessed for the 
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box 1 summary of rapid Assessment of Avoidable 
blindness (rAAb)
The main aims of rAAb are:
 ► To estimate the prevalence and causes of blindness and 
visual impairment in people aged 50 years and above.
 ► To assess cataract surgical coverage.
 ► To identify the main barriers to uptake of cataract surgery.
 ► To measure outcome after cataract surgery.
 ► To provide baseline data for planning of eye care services and 
to monitor and evaluate ongoing programmes.
Why carry out a rAAb survey?
 ► To help eye health managers to develop programmes for 
control of visual impairment based on a community’s needs.
 ► To help to monitor existing eye health programmes and to 
adjust these programmes as and when required.
What rAAb is not:
 ► RAAB is not a case-finding exercise: it will not provide a list 
of names and addresses of all people who are blind due to 
(for example) cataract in an area.
 ► RAAB is not a detailed blindness survey: it provides a 
reasonably accurate estimate of the prevalence of blindness, 
and the proportion that is avoidable in a geographic area. 
RAAB is not designed to give accurate estimates of the 
prevalence of specific causes of blindness and does not 
measure posterior segment disease in detail.
 ► RAAB focuses on people aged 50 years and above and so it 
does not give an estimate of prevalence in children or people 
younger than 50 years.
presence of cataract using a torch and a direct ophthalmo-
scope, and in some settings, a portable slitlamp (optional). 
People with visual acuity below <6/12 have pinhole vision 
taken, and are examined by the ophthalmologist to ascertain 
the main cause of visual loss. Dilatation drops are admin-
istered to aid examination, in the event that the cause of 
visual loss is not identified as refractive error, cataract or 
other anterior segment causes (eg, corneal opacity). Steps are 
taken to improve standardisation of disease classification, 
including during training and by data entry prompts (eg, if 
there is an improvement in vision to 6/12 after pinhole then 
it is flagged that the cause should be registered as refractive 
error). However, it is not possible to diagnose the presence of 
specific posterior segment diseases with accuracy, given that 
the examination relies on direct ophthalmoscopy, without 
slit lamps (usually) or the ability to measure intraocular 
pressure or visual fields. The exception is when a specific 
diabetic retinopathy (DR) protocol is added to RAAB, as 
discussed below. If posterior segment disease assessment is 
the main priority of the study then a more detailed examina-
tion protocol is needed.6
 ► Resources: Key resources are available to support these two 
steps. A RAAB software package is available, which supports 
sample size estimation, selection of clusters, data entry and 
data analysis. In addition, a standardised training package 
has been developed (including a manual and PowerPoint 
slides) to ensure that the training of RAAB staff is under-
taken consistently, and to a high standard.
Each RAAB takes approximately 1–6 months to complete, 
including 1 week of training (depending on the sample size, the 
number of teams, transport and time). RAAB was developed for 
use in low-income and middle-income countries (LMICs), and 
few RAABs have been completed in high-resource settings.
The RAAB method is ‘rapid’ for three reasons. First, only 
people aged 50 years and above are included. The prevalence of 
visual impairment is highest in this age group and therefore, the 
required sample size is lower. For instance, estimates from the 
Gambia show that only 9% of the population was aged 50 years 
or more, yet they accounted for 84% of the cases of blindness.7 
Consequently, restricting the survey to this age group reduces 
the required sample size and costs substantially, while the causes 
of blindness in this sample have been shown to be reflective of 
the causes in the total population. People of this age are more 
likely to be at home giving a high response rate. Second, rela-
tively quick and simple eye examinations are undertaken relying 
on direct ophthalmoscopy. This examination approach is appro-
priate for identifying an uncorrected refractive error or anterior 
segment causes of visual loss (eg, cataract and corneal opacity), 
which remain the leading causes of blindness and visual loss in 
most LMICs.8 Third, the RAAB software programme includes a 
predesigned data-entry form, and allows automated data anal-
ysis. This step is helpful as it removes the time required for statis-
tical analysis as well as the need for specialist statisticians. It also 
ensures that data analyses are comparable across all RAABs.
An additional DR module has been developed to be incorpo-
rated in areas where the prevalence of diabetes is high (although 
a specific threshold has not been established), such as in the 
Middle East, Latin America or other middle-income or urban 
settings.9 10 Here, all participants undergo random blood sugar 
(RBS) testing, and those who are known diabetics or have an 
RBS of 200 mg/dL or 11.1 mmol/L have a dilated retinal exam-
ination or images taken for DR screening. This component 
allows planning of DR services, but it will increase the cost of 
the RAAB and adds to its complexity, and so is not recommended 
for all circumstances. Furthermore, the prevalence of DR is often 
around 20%–40% among diabetics, and so can be estimated if 
the prevalence of diabetes is known.9–12
There are also further adaptations of the standard RAAB 
protocol. As an example, RAAB has been expanded to include 
children in some settings, as in Vietnam, where a series of 16 
RAABs were conducted and these included sampling of children 
<15 years to allow estimation of the prevalence and causes of 
blindness in children.13 The Rapid Assessment of Visual Impair-
ment expands the RAAB protocol to people aged 40 years and 
above and includes assessment of near vision, but only defines 
causes in terms of cataract, refractive error or other causes.14 
The Rapid Assessment of Refractive Error includes a sample 
of people aged 15–50 years, and focusses on the assessment of 
uncorrected refractive error and presbyopia.15
WhAT Are The AChIevemenTs of rAAb?
To date, at least 331 RAABs have been undertaken in 79 coun-
tries.16 To put these figures into context, this is substantially 
more data than is available for most other impairment types, 
where standardised rapid assessment survey methods are 
currently lacking. As examples, a recent review identified only 
42 studies from 29 countries that showed the prevalence of 
hearing loss,17 and another review identifed only 36 studies since 
2000 that estimate the prevalence of autism and other pervasive 
developmental disorders, the vast majority of which were from 
high-income settings.18 Within Africa, specifically, at least 64 
RAABs have been undertaken, and by contrast, a recent review 
identified only eight population-based surveys of hearing impair-
ment.19 The RAABs have also made an important contribution to 
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box 2 systems to maintain quality of rapid Assessment 
of Avoidable blindness (rAAb) data collected
 ► Certified RAAB trainers are available in all continents to 
maintain the standards for planning, training and data 
collection in RAABs.
 ► Data entry system of RAAB uses a wide range of validation 
rules to ensure complete and valid data.
 ► RAAB software provides detailed standardised and automatic 
data analysis. This ensures uniformity in data analysis and 
makes results comparable between RAABs.
 ► Before RAAB data are included in the repository, the 
webmaster (Hans Limburg) checks quality parameters (eg, 
response rate), violations of the validity rules, cluster size, 
non-compliance, design effect, and so on, to ascertain 
whether the data are of a sufficient standard.
 ► Ideally, journals would consider the publication of RAAB 
reports only after inclusion of these reports in the repository, 
as these have used the RAAB protocol and data analysis, 
and have passed through quality control. Several studies 
were published in the scientific literature as ‘RAAB’, while 
these did not follow the RAAB protocol or used custom data 
analysis.
the global data on blindness. The latest Global Burden of Disease 
report included data from 124 RAABs (personal communication).
A RAAB repository has been developed to store RAAB data 
and allow comparison of data across different settings and times. 
The repository includes the area and date of RAABs that have 
been undertaken, and, where authors have agreed, the core indi-
cators (sample size, coverage, prevalence of conditions: blind-
ness, low vision, functional low vision, cataract, refractive error, 
trachoma, posterior segment disease and DR, cataract surgical 
coverage, cataract surgical outcome and intraocular lens%); 
publications, reports or even raw data from the survey are avail-
able.16 The repository currently includes 331 entries (January 
2019), but more RAABs may have been undertaken, unknown 
to the repository. Steps are in place to ensure that the quality of 
RAAB is maintained, so that the data are reliable (box 2). This 
repository, therefore, provides a rich source of data, with oppor-
tunities for cross-country analysis. As one example, Ramke et 
al assessed studies from the RAAB repository to identify how 
many had been published in the scientific literature to estimate 
‘avoidable waste’ through findings not being made publicly 
available.20 Others have compared the ratio between the preva-
lence of low vision and blindness across RAAB surveys.21 There 
are many more opportunities to use this resource, such as to 
estimate the need for low vision services, trends over time or 
between regions, or to compare levels of indicators, such as poor 
surgical outcomes.
WhAT developmenTs Are beIng plAnned for rAAb?
Despite these achievements, there are core areas in which RAAB 
needs to be strengthened so that the full benefits of undertaking 
the survey can be reaped. In 2015, a mobile (Android)-based 
data collection app for RAAB6 (mobile RAAB - mRAAB) was 
released improving the speed and accuracy of data collection, 
as well as eliminating the need for manual data entry of survey 
forms into the RAAB software programme. Further develop-
ments of RAAB7 are underway. These plans fall into three main 
categories: (1) improvements in our ability to use RAAB data 
for planning, (2) improvements in the data collected and (3) 
integration of technological advances into data collection and 
examination procedures.
 ► Planning: The main aim of RAAB is to generate data that 
can be used for planning of eye care services, and answering 
questions such as how many cataract surgeries should be 
undertaken. However, currently, RAAB generates data on 
the prevalence of visual loss and its causes, which are less 
tangible indicators for planners. Translating these figures 
into actionable plans, therefore, requires additional steps, 
which are not always made. A needs assessment is required 
to complement the RAAB, which will collect data on human 
resources and available services, in order to identify where 
there are gaps and issues that must be addressed by the plans 
(eg, insufficient ophthalmic staff and lack of specialist equip-
ment). Additionally, approaches on how to develop eye care 
plans need to be improved. For instance, planning should 
include identifying key influencers early in the process and 
ensuring that they are engaged throughout the planning, 
conduct and interpretation of RAAB. Development of the 
planning module is currently in process and will be launched 
during 2020.
 ► Additional data collection: It is increasingly recognised that 
populations are not homogenous, and that certain groups 
will be particularly vulnerable to visual loss or face addi-
tional difficulties in accessing services. Examples of vulner-
able groups include women, people living in poverty and 
people with disabilities. RAAB already allows disaggregation 
of data by gender to assess whether women have different 
needs to men in terms of eye care service provision. The 
updated version of RAAB will also include an equity tool, 
to measure socioeconomic status, as well as the Washington 
Group questions to ascertain the presence of disability.22 
These new indicators will allow further inspection of the 
data to see whether plans need to be adapted take particular 
account of these subgroups.23 Specific indicators measured 
in RAAB may also need to be improved. As an example, 
RAAB collects barriers to accessing cataract surgery by 
people who need this service, but this component can be 
strengthened. Common barriers are almost invariably lack 
of awareness that services are available and lack of money 
to pay for services. However, previous research has shown 
that quantitative reports on barriers are too simplistic, and 
that qualitative data are needed, though this is difficult to 
incorporate into a survey.24 Approaches for the collection of 
barrier data are being reconsidered.
 ► Technology: Technological developments are creating 
fantastic new opportunities for RAAB. Peek is a public 
eye health platform that includes a portfolio of smart-
phone-based tools for ophthalmic assessment. The Peek 
Acuity vision test app is simple to perform and compares 
well to gold-standard LogMar,25 and is being integrated into 
RAAB7 to replace the paper-based tumbling E chart. The 
advantages of using Peek for visual acuity assessment is that 
it is more accurate, can be measured at distances of less than 
6 metres (not possible with paper-based versions) and field-
workers enjoy using it, finding it motivating. An IOS version 
will be developed, to complement the Android tools. In 
future, other technological advances may be developed that 
will improve diagnostic accuracy of eye conditions further—
such as the development of a high-quality low-cost portable 
retinal camera, which could allow remote diagnosis of poste-
rior segment eye disease, such as DR. Other mobile tools are 
at an early stage of development and testing, for instance, to 
measure visual fields, could to aid the diagnosis of glaucoma, 
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while automated grading could facilitate remote diagnosis. 
Another development of RAAB7 is that it will operate 
through uploading data collected on mobile devices directly 
to the cloud, which will allow mid-survey checking of data, 
so that teams can be monitored to assess whether they are 
getting unlikely or divergent results, and allow quality issues 
to be flagged at an earlier point. This development will also 
mean that a backup of the data files is saved to the reposi-
tory (pending permission from the principal investigator), 
which does not currently happen. An assessment is currently 
underway of the feasibility of cloud-based data storage, 
taking into account information governance issues, such as 
the varying requirements for different countries.
 ► Data visualisation: Including more sophisticated tools to 
visualise and model the data within the repository may help 
to make it more user-friendly to a wider range of audiences, 
such as district-level planners, policymakers and the general 
public. Data visualisation could allow the extrapolation of 
data to the country, generation of all-age estimates and fore-
casting trends in visual impairment into the future. These 
visual tools are currently being developed under the RAAB 
updates.
There are also future challenges for RAAB. Cataract and 
uncorrected refractive error will remain the priorities of eye 
health services in many LMICs. However, in the coming 
decades, posterior segment disease will make up a larger propor-
tion of the need. This pattern is already clear in high-income 
countries, and therefore RAAB will need to improve its ability 
to identify posterior segment causes of visual loss. This will 
add to the complexity of undertaking RAABs, as it will require 
improved ability to make diagnoses in the field (eg, visual field 
and intraocular pressure examinations and availability of more 
skilled professionals able to make the diagnoses), but would 
also increase diagnostic accuracy. Costs will consequently also 
increase, which may reduce the capacity for undertaking RAABs; 
for comparison, conducting a RAAB plus DR is approximately 
50% more expensive than a standard RAAB.
Our experience suggests that undertaking RAAB in high-in-
come countries may be more challenging,26 and has consequently 
rarely been undertaken. RAABs may therefore become more 
complex to complete, potentially with lower response rates, as 
settings become more economically developed and urbanised. 
This challenge may require the development of new sampling 
methods, particularly for high-rise urban settings.
ConClusIon
RAABs have made major contributions towards our under-
standing of the epidemiology of global blindness. The world is 
changing in terms of patterns and causes of disease, including 
eye disease, as well as the technology available. RAAB needs 
to take advantage of new opportunities and adapt to changing 
needs in order to stay relevant and widely used, and to continue 
contributing towards global eye health.
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